We are live on ! Find out more
CLBT icon

Cellebrite

201 hedge funds and large institutions have $1.83B invested in Cellebrite in 2026 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 81 increasing their positions, 60 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more call options, than puts

Call options by funds: $10.7M | Put options by funds: $5.89M

35% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 60

5% more capital invested

Capital invested by funds: $1.74B → $1.83B (+$88.3M)

0.45% less ownership

Funds ownership: 50.76%50.31% (-0.45%)

9% less funds holding

Funds holding: 221201 (-20)

17% less funds holding in top 10

Funds holding in top 10: 1210 (-2)

32% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 53

Holders
201
Holders Change
-20
Holders Change %
-9.05%
% of All Funds
2.42%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.12%
New
36
Increased
81
Reduced
60
Closed
53
Calls
$10.7M
Puts
$5.89M
Net Calls
+$4.85M
Net Calls Change
+$2.77M

CLBT Hedge Fund Activity: Q2 2026 in Review

201 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q2 2026, worth a combined $1.83B — up 5.1% from $1.74B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of CLBT and 36 opened new positions — a net loss of 17 holders — while 60 trimmed existing stakes and 81 added.

The largest buyer was BlackRock, adding an estimated $31M. The largest seller was Fidelity Investments, cutting an estimated $33.3M.

  • 201 institutional investors held Cellebrite (CLBT) as of Q2 2026, down from 221 in Q1 2026.
  • Funds reported $1.83B of Cellebrite stock for Q2 2026, up 5.1% quarter-over-quarter.
  • 36 funds opened new Cellebrite positions in Q2 2026 and 53 closed out, a net change of -17 holders.
  • The largest Cellebrite buyer in Q2 2026 was BlackRock, an estimated $31M added.
  • The largest Cellebrite seller in Q2 2026 was Fidelity Investments, an estimated $33.3M sold.

Based on aggregated 13F filings for Q2 2026.